spacer
home > pmps > winter 2002 > the financial and operational benefits of e-learning in regulatory compliance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Financial and Operational Benefits of e-Learning in Regulatory Compliance

We believe that e-learning will increasingly be employed by pharmaceutical organisations to achieve and maintain compliance training as mandated by the regulatory authorities. e-Learning not only enhances compliance initiatives but also delivers the benefits of improved operational efficiency and higher profitability. Given the global nature of today's pharmaceutical operations, as well as an increased regulatory burden, e-learning has found a niche in the pharmaceutical manufacturing process, and ties in well with new FDA technology initiatives.

It has been well documented that e-learning cuts down the learning curve and delivers significant cost savings associated with traditional instructor led training (ILT). Furthermore, its interactive nature improves employee (student) material retention rates, and offers companies with customised solutions to their training needs. Since e-learning and computer-based training (CBT) integrates and complements traditional classroom-based training programmes, companies could achieve higher employee productivity by adopting a blended approach to learning.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Chakri Lokapriya, Managing Consultant - Compliance Solutions, and Tony Kypreos, Chief Commercial Officer, at Maersk Data UK
Chakri Lokapriya is Managing Consultant - Compliance Solutions at Maersk Data UK, a company which provides tailored audits and pilots in the areas of validation process, electronic records and signatures and computer validation. Prior to this, he was an Equity Analyst covering health care companies at JP Morgan and UBS Warburg. Chakri is a Director of Prinvex.

Tony Kypreos is Chief Commercial Officer at Maersk Data UK. Prior to this, he was European Vice-President of Strategic Services at Omnicom Group, and for nine years he held senior marketing and sales roles for Nestlй and Diageo.


spacer
Chakri Lokapriya
spacer
spacer
spacer
Tony Kypreos
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Introduces New Integrated Plug & Play Upstream Development Service

• Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-up • Tailored upstream development from a single source reduces time to clinic by 20 percent • Fast-track process reduces timeline by 10 weeks for first pharmacodynamic experiment
More info >>

White Papers

Generating Scientific Insights by Deep Collaboration - Bridging the Big Data Divide Between Clinical and Research

BioFortis

Translational research, biomarker discovery, clinical studies and even biobanking have become increasingly data intensive.  However, generating scientific insights from such disparate “big” data sources across multiple domains is a challenge for both researchers and the informaticians that support them. Download our Deep Collaboration Whitepaper and and learn how to bridge the clinical and research divide to better explore your biomarker based trials.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement